Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry

Jean-Marc Fritschy1

  • 1Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. fritschy@pharma.uzh.ch

Insights

Tissue fixation significantly impacts immunohistochemistry (IHC) results by altering antigenicity. Proper antibody characterization, including fixation susceptibility, is crucial for reliable brain cytoarchitecture studies.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Immunohistochemistry (IHC) is vital for brain cyto- and chemoarchitecture research.
  • Antibody specificity is critical, requiring validation to prevent false positives from non-specific binding.
  • Tissue fixation and processing can significantly affect antigenicity and antibody accessibility.

Purpose of the Study:

  • To highlight overlooked pitfalls in immunohistochemistry experiments.
  • To emphasize the impact of tissue fixation on antigenicity and staining outcomes.
  • To define minimal reporting standards for reproducible IHC in publications.

Main Methods:

  • Review of common immunohistochemistry pitfalls, focusing on tissue fixation.
  • Illustrative immunoperoxidase staining experiments using mouse tissue.
  • Variations in tissue fixation strength and postfixation times were applied.

Main Results:

  • Fixation can abolish specific immunostaining or necessitate prolonged postfixation.
  • Antibodies exhibit varying susceptibility to fixation-induced epitope masking or conformational changes.
  • Non-specific background staining can be influenced by fixation protocols.

Conclusions:

  • Tissue fixation is a critical variable that strongly influences IHC results.
  • Characterizing antibody fixation susceptibility is essential for optimizing IHC protocols.
  • Standardized reporting of fixation methods is necessary for IHC reproducibility.